Abstract
We investigated the efficacy of activated cannabinoid 2 receptors for alleviating ovarian ischemia-reperfusion injury in rats. Female Wistar albino rats were divided randomly into six groups: ischemia-reperfusion (IRG); ischemia-reperfusion + 0.2 mg/kg JWH-133 (JIRG1), ischemia-reperfusion + 1 mg/kg JWH-133 (JIRG2); ischemia-reperfusion + 5 mg/kg JWH-133 (JIRG3); solvent control, and sham control. Ovarian ischemia was established for 3 h followed by reperfusion for 3 h. Ovarian tissue was investigated using histology, immunohistochemistry and biochemistry. Administration of JWH-133 synthetic cannabinoid reduced nuclear factor kappa-B immunoreactivity as well as TUNEL positivity scores and malondialdehyde levels. These reductions were significant in all cases except for the malondialdehyde levels in the 1 mg/kg JWH-133 group. Activation of cannabinoid 2 receptors by JWH-133 reduced ovarian ischemia-reperfusion injury due to its antioxidant and anti-inflammatory effects.
Keywords: Cannabinoid 2 receptors, inflammation, ischemia-reperfusion injury, JWH-133, oxidative stress
Similar articles
-
The Activation of Cannabinoid Type-2 Receptor with JWH-133 Protects Uterine Ischemia/Reperfusion-Induced Damage.Pharmacology. 2021;106(1-2):106-113. doi: 10.1159/000511457. Epub 2020 Oct 26.PMID: 33105141
-
The protective effect of cannabinoid type 2 receptor activation on renal ischemia-reperfusion injury.Mol Cell Biochem. 2019 Dec;462(1-2):123-132. doi: 10.1007/s11010-019-03616-6. Epub 2019 Aug 24.PMID: 31446615
-
Exogenous activation of cannabinoid-2 receptor modulates TLR4/MMP9 expression in a spinal cord ischemia reperfusion rat model.J Neuroinflammation. 2020 Apr 6;17(1):101. doi: 10.1186/s12974-020-01784-7.PMID: 32248810 Free PMC article.
-
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion.J Mol Cell Cardiol. 2009 May;46(5):612-20. doi: 10.1016/j.yjmcc.2008.12.014. Epub 2009 Jan 7.PMID: 19162037
-
The effect of rutin on ovarian ischemia-reperfusion injury in a rat model.Gynecol Endocrinol. 2018 Sep;34(9):809-814. doi: 10.1080/09513590.2018.1450378. Epub 2018 Mar 22.PMID: 29564969